Brief Behavioral Activation Treatment for Depression With Inpatients

Depression Clinical Trial

Official title:

An Evaluation of Brief Behavioral Activation Treatment for Depression With Moderate to Severely Depressed Inpatients - A Small Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02712918
• Other study ID #: BATD_16674
• Status: Completed
• Phase: N/A
• First received: March 9, 2015
• Last updated: March 15, 2016
• Start date: January 2014
• Est. completion date: October 2014

Study information

• Verified date: March 2016
• Source: Lovisenberg Diakonale Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Data Protection Authority
• Study type: Interventional

Clinical Trial Summary

The purpose of the current study was to examine Brief Behavioral Activation Treatment for Depressions (BATD) effectiveness, credibility, and acceptability with moderate to severly depressed inpatients. The study is a systematic replication of a randomized controlled trail from 2003, that provided initial support for BATD With inpatients. The current study compared BATD to Treatment as Usual in a randomized controlled trial.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 23
• Est. completion date: October 2014
• Est. primary completion date: October 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Moderate to severe depression (BDI-II > 28 Points).

• Admission length of at least 3 days

• Evaluated to benefit from depression treatment by unit psychiatrist.

Exclusion Criteria:

• Current psychotic disorder

• Previously diagnosis with psychotic disorder (including Bipolar disorder)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Behavioral:
• Brief Behavioral Activation Treatment for Depression
Behavioral treatment of depression which focuses on increasing the Level of positive reinforcement through systematic and goal directed activation of behavior. Goal and values are assessed and used to determine target behaviors.

Other:
• Standard Care
Treatment as usual at the ward

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Lovisenberg Diakonale Hospital	Oslo and Akershus University College of Applied Sciences

References & Publications (3)

Hopko DR, Lejuez CW, LePage JP, Hopko SD, McNeil DW. A brief behavioral activation treatment for depression. A randomized pilot trial within an inpatient psychiatric hospital. Behav Modif. 2003 Sep;27(4):458-69. — View Citation

Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual. Behav Modif. 2011 Mar;35(2):111-61. doi: 10.1177/0145445510390929. — View Citation

Lejuez CW, Hopko DR, Hopko SD. A brief behavioral activation treatment for depression. Treatment manual. Behav Modif. 2001 Apr;25(2):255-86. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change of Beck`s Depression Inventory-II from baseline		Change from baseline (second day of admission) to discharge from the ward (maximum 21 days, expected average of 10 days).	No
Secondary	Credibility and Expectancies Questionnaire	Only BATD group	Second day of admission. After first sessions of BATD.	No
Secondary	Treatment Evaluation Inventory - Short Form	Only BATD group	Prior to discharge from the ward (maximum 21 days, expected average of 10 days)..	No